Cancer cells are known for their ability to evade the body’s immune defenses. While the immune system is designed to detect and destroy abnormal cells, including cancerous ones, some cancer cells can resist these attacks. Even more surprisingly, the inflammation caused by immune cells—initially helpful in identifying and fighting tumors—can eventually help cancer cells survive and grow. This paradoxical relationship between the immune system and cancer has intrigued scientists for years. A team of researchers from the Salk Institute in California has uncovered a key biological mechanism that explains how this happens. According to Gerald Shadel, lead author of the study, "Cancer cells have a remarkable ability to adapt to the pressures of the immune system." The study reveals that certain immune signals, which are initially beneficial in the fight against cancer, can be turned against the body if they persist over time. These signals are called interferons, proteins that act as part of the body's alarm system, alerting immune cells to the presence of threats like viruses or cancer. However, when interferons remain active for too long, they can cause cellular stress, particularly affecting mitochondria—the parts of cells responsible for producing energy. This disruption can create an environment that supports tumor growth instead of stopping it. The study highlights how cancer cells can exploit this prolonged inflammation to enhance their survival and proliferation. This finding adds a new layer of understanding to the complex relationship between the immune system and cancer. The results of this research have been published in the journal Science, offering new insights into how cancer cells manipulate immune responses. This knowledge may lead to more effective treatments that target not only the cancer itself but also the ways in which it co-opts the immune system to its advantage.